Companies that own Chiasma Inc.
Fidelity Management & Research Co.
2,710,391
11.12%
0
0%
06/30/2018
Point72 Asset Management LP
896,600
3.68%
81,205
0.01%
06/30/2018
Rock Springs Capital Management LP
525,000
2.15%
0
0.05%
06/30/2018
Bridgeway Capital Management, Inc.
352,600
1.45%
-19,789
0.01%
06/30/2018
The Vanguard Group, Inc.
227,353
0.93%
0
0%
06/30/2018
BlackRock Fund Advisors
168,547
0.69%
10,914
0%
06/30/2018
G1 Execution Services LLC
69,712
0.28%
69,712
0.01%
06/30/2018
Renaissance Technologies LLC
68,400
0.28%
-30,613
0%
06/30/2018
DWS Investment GmbH
62,778
0.26%
-24,039
0%
06/30/2018
DRW Securities LLC
57,000
0.23%
0
0.01%
06/30/2018
| Address |
460 Totten Pond Road
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.chiasmapharma.com |
| Updated |
07/08/2019 |
| Chiasma, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing and commercializing oral forms of therapies that are available by injection. Its products include octreotide capsules and clinical trials. The company's Transient Permeability Enhancer (TPE) technology platform, seeks to develop oral medications. |
